Stock Comparison

ABBV vs OSCR

AbbVie Inc vs Oscar Health Inc

The Verdict

OSCR takes this one.

ABBV

AbbVie Inc

0.1

out of 10

Distressed

Winner

OSCR

Oscar Health Inc

8.5

out of 10

Hidden Gem

Head-to-Head

$381.1B

Market Cap

$8.4B

104.8

P/E Ratio

49.6

5.8%

Profit Margin

-0.3%

95.6%

Return on Equity

-3.3%

20.2

Debt-to-Equity

0.4

Moderate

Overall Risk

Aggressive

0.1

DVR Score

8.5

The Deep Dive

ABBV0.1/10

AbbVie (ABBV) remains a well-established mega-cap pharmaceutical company, demonstrating stable, incremental growth driven by its robust immunology portfolio, notably Skyrizi and Rinvoq. Q1 2026 results showed modest revenue and adjusted EPS growth, with slightly raised full-year guidance. While financially healthy and a strong dividend payer, its immense market capitalization ($381.10B) and the ma...

Full ABBV Analysis

OSCR8.5/10

Oscar Health's Q1 2026 results represent a material positive shift, showcasing exceptional profitability with a net income of ~$679M and a 15.2% operating margin on $4.65B revenue, exceeding previous analysis's general mention of beating consensus. This strongly validates its operational turnaround and path to market leadership in insurtech. The reaffirmation of robust full-year 2026 revenue guida...

Full OSCR Analysis

Want More Comparisons?

Run any stock through our deep value analyzer.

Analyze Any Stock →

Not Financial Advice

This comparison is for educational purposes only. We are not financial advisors. Always do your own research and consult a qualified advisor before investing.